News

Biotech, health IT stocks have a bad January  | Health IT

By January 31, 2022No Comments

As investors prepare for the Federal Reserve to raise interest rates, the health IT and biotechnology sectors have lost momentum and suffered losses, Nasdaq reported Jan. 30. Health IT

Leave a Reply